➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
AstraZeneca
Johnson and Johnson
Colorcon
Medtronic

Last Updated: January 25, 2021

DrugPatentWatch Database Preview

Sciegen Pharms Inc Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for SCIEGEN PHARMS INC, and what generic and branded alternatives to SCIEGEN PHARMS INC drugs are available?

SCIEGEN PHARMS INC has thirty-nine approved drugs.



Summary for Sciegen Pharms Inc
US Patents:0
Tradenames:33
Ingredients:32
NDAs:39

Drugs and US Patents for Sciegen Pharms Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sciegen Pharms Inc HYDRALAZINE HYDROCHLORIDE hydralazine hydrochloride TABLET;ORAL 205236-003 May 26, 2017 AA RX No No   Start Trial   Start Trial
Sciegen Pharms Inc NAPROXEN naproxen TABLET;ORAL 212517-001 Feb 21, 2020 AB RX No No   Start Trial   Start Trial
Sciegen Pharms Inc IRBESARTAN irbesartan TABLET;ORAL 204774-002 Dec 7, 2015 AB RX No No   Start Trial   Start Trial
Sciegen Pharms Inc ROSUVASTATIN CALCIUM rosuvastatin calcium TABLET;ORAL 206381-002 Apr 24, 2019 DISCN No No   Start Trial   Start Trial
Sciegen Pharms Inc LAMOTRIGINE lamotrigine TABLET, ORALLY DISINTEGRATING;ORAL 206382-003 Jun 17, 2016 AB RX No No   Start Trial   Start Trial
Sciegen Pharms Inc SERTRALINE HYDROCHLORIDE sertraline hydrochloride TABLET;ORAL 076442-001 Apr 30, 2007 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Mallinckrodt
Baxter
AstraZeneca
Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.